NXP Semiconductors Announces Realignment of Business Segments
EINDHOVEN, THE NETHERLANDS--(Marketwired - Apr 11, 2013) - NXP Semiconductors N.V. ( NASDAQ : NXPI ) today announced the realignment of several product lines to better reflect underlying market dynamics, product complexity and the management of the business. The changes include:
- Movement of product line General Purpose Logic (GPL) from segment High Performance Mixed Signal (HPMS), end-market Portable & Computing to segment Standard Products.
- Movement of product line NXP Software from Corporate and Other to segment HPMS, end-market Industrial & Infrastructure.
In addition, to enable improved comparisons of underlying operating performance relative to industry peers, the company will exclude stock-based compensation from its GAAP to non-GAAP reconciliation.
The impact of these changes are reflected in the summary tables below and detailed in the attached tables based on the company's most recent reported financial results for the fourth quarter and full-year 2012, ended December 31, 2012. A full reconciliation of the impact of the changes to reported historical financial results is provided on NXP's investor relations website, under the "Financial Results" section at http://investors.nxp.com .
Reclassified Results for the Fourth Quarter and Full Year 2012 ($ millions, except EPS, unaudited)
| |
|
Q4 2012 |
|
|
Q3 2012 |
|
|
Q4 2011 |
|
|
Q - Q |
|
|
Y - Y |
|
|
2012 |
|
|
2011 |
|
|
Y - Y |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Product Revenue |
|
$ |
1,072 |
|
|
$ |
1,120 |
|
|
$ |
868 |
|
|
-4.3 |
% |
|
23.5 |
% |
|
$ |
4,144 |
|
|
$ |
3,869 |
|
|
7.1 |
% |
| Manufacturing Operations |
|
$ |
43 |
|
|
$ |
49 |
|
|
$ |
62 |
|
|
-12.2 |
% |
|
-30.6 |
% |
|
$ |
211 |
|
|
$ |
316 |
|
|
-33.2 |
% |
| Corporate & Other |
|
$ |
1 |
|
|
$ |
1 |
|
|
$ |
1 |
|
|
0.0 |
% |
|
0.0 |
% |
|
$ |
3 |
|
|
$ |
9 |
|
|
-66.7 |
% |
| Total Revenue |
|
$ |
1,116 |
|
|
$ |
1,170 |
|
|
$ |
931 |
|
|
-4.6 |
% |
|
19.9 |
% |
|
$ |
4,358 |
|
|
$ |
4,194 |
|
|
3.9 |
% |
| GAAP Gross Profit |
|
$ |
490 |
|
|
$ |
536 |
|
|
$ |
389 |
|
|
-8.6 |
% |
|
26.0 |
% |
|
$ |
1,988 |
|
|
$ |
1,906 |
|
|
4.3 |
% |
| |
Gross Profit Adjustments (1) |
|
$ |
(25 |
) |
|
$ |
(7 |
) |
|
$ |
(34 |
) |
|
|
|
|
|
|
|
$ |
(8 |
) |
|
$ |
(81 |
) |
|
|
|
| Non-GAAP Gross Profit |
|
$ |
515 |
|
|
$ | 543 |
|
|
$ |
423 |
|
|
-5.2 |
% |
|
21.7 |
% |
|
$ |
1,996 |
|
|
$ |
1,987 |
|
|
0.5 |
% |
| |
GAAP Gross Margin |
|
|
43.9 |
% |
|
|
45.8 |
% |
|
|
41.8 |
% |
|
|
|
|
|
|
|
|
45.6 |
% |
|
|
45.4 |
% |
|
|
|
| |
Non-GAAP Gross Margin |
|
|
46.1 |
% |
|
|
46.4 |
% |
|
|
45.4 |
% |
|
|
|
|
|
|
|
|
45.8 |
% |
|
|
47.4 |
% |
|
|
|
| GAAP Operating Income |
|
$ |
33 |
|
|
$ |
168 |
|
|
$ |
7 |
|
|
-80.4 |
% |
|
371.4 |
% |
|
$ |
412 |
|
|
$ |
357 |
|
|
15.4 |
% |
| |
Operating Income Adjustments (1) |
|
$ |
(192 |
) |
|
$ |
(76 |
) |
|
$ |
(150 |
) |
|
|
|
|
|
|
|
$ | (422 |
) |
|
$ |
(476 |
) |
|
|
|
| Non-GAAP Operating Income |
|
$ |
225 |
|
|
$ |
244 |
|
|
$ |
157 |
|
|
-7.8 |
% |
|
43.3 |
% |
|
$ |
834 |
|
|
$ |
833 |
|
|
0.1 |
% |
| |
GAAP Operating Margin |
|
|
3.0 |
% |
|
|
14.4 |
% |
|
|
0.8 |
% |
|
|
|
|
|
|
|
|
9.5 |
% |
|
|
8.5 |
% |
|
|
|
| |
Non-GAAP Operating Margin |
|
|
20.2 |
% |
|
|
20.9 |
% |
|
|
16.9 |
% |
|
|
|
|
|
|
|
|
19.1 |
% |
|
|
19.9 |
% |
|
|
|
| GAAP Net Income / (Loss) |
|
$ |
(116 |
) |
|
$ |
115 |
|
|
$ |
(182 |
) |
|
NM |
|
|
NM |
|
|
$ |
(115 |
) |
|
$ |
390 |
|
|
NM |
|
| |
Net Income Adjustments (1) |
| $ |
(258 |
) |
|
$ |
(39 |
) |
|
$ |
(250 |
) |
|
|
|
|
|
|
|
$ |
(592 |
) |
|
$ |
(65 |
) |
|
|
|
| Non-GAAP Net Income / (Loss) |
|
$ |
142 |
|
|
$ |
154 |
|
|
$ |
68 |
|
|
-7.8 |
% |
|
108.8 |
% |
|
$ |
477 |
|
|
$ |
455 |
|
|
4.8 |
% |
| GAAP EPS |
|
$ |
(0.47 |
) |
|
$ |
0.45 |
|
|
$ |
(0.73 |
) |
|
NM |
|
|
NM |
|
|
$ |
(0.46 |
) |
|
$ |
1.57 |
|
|
NM |
|
| |
EPS Adjustments (1) |
|
$ |
(1.03 |
) |
|
$ |
(0.16 |
) |
|
$ |
(1.00 |
) |
|
|
|
|
|
|
|
$ |
(2.34 |
) |
|
$ |
(0.23 |
) |
|
|
|
| Non-GAAP EPS |
|
$ |
0.56 |
|
|
$ |
0.61 |
|
|
$ |
0.27 |
|
| -8.2 |
% |
|
107.4 |
% |
|
$ |
1.88 |
|
|
$ |
1.80 |
|
|
4.4 |
% |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1) Please see "Discussion of GAAP to non-GAAP Reconciliation"
Reclassified Supplemental Information (revenue, $ millions, unaudited)
| |
Q4 2012 |
|
Q3 2012 |
|
Q4 2011 |
|
Scroll down for more posts ▼
Top 10 Most Recent News Articles
BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...
Continue Reading
Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....
Continue Reading
Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...
Continue Reading
Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...
Continue Reading
What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...
Continue Reading
New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...
Continue Reading
Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...
Continue Reading
Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...
Continue Reading
Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...
Continue Reading
Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...
Continue Reading
Top 5 Most Recently Viewed Articles
Viatris Launches Cash Tender Offers for Outstanding Notes Viatris Inc. (NASDAQ: VTRS), a leading player in the global healthcare sector, has initiated tender offers to acquire certain outstanding notes. This move is designed to strengthen its financial framework and enhance returns for its shareholders. Notably, the offers include various senior notes that were originally...
Continue Reading
Coke Florida Kicks Off Holiday Spirit with Caravan Tour Coca-Cola Beverages Florida, LLC (Coke Florida) is thrilled to share that its beloved annual "Holiday Caravan" is set to return. This event, which has become an essential part of the holiday season, features the iconic Coca-Cola red delivery truck decked out in festive cheer. Families will enjoy complimentary samples...
Continue Reading
Nexxen's Upcoming Participation at RBC Global Conference Nexxen International Ltd. (AIM/NASDAQ: NEXN), a leading global advertising technology platform, is geared up to take part in a significant event, the RBC Global Technology, Internet, Media and Telecommunications Conference. This event provides a stellar opportunity for companies to connect with investors and share...
Continue Reading
GayVeterans.us Achieves 501(c)(3) Tax Exempt Status GayVeteransUS-Inc. has recently been granted 501(c)(3) tax-exempt status, marking a significant milestone for the organization. This designation enables supporters to make tax-deductible contributions, strengthening the community's ability to provide enhanced resources and support. The dedication of veteran volunteers...
Continue Reading
Virbac Enhances Its Offerings with Felanorm Acquisition Virbac has announced a significant acquisition that marks a pivotal moment in its commitment to improving the health and quality of life for senior cats. This globally recognized drug is aimed at treating feline hyperthyroidism, a condition that is becoming increasingly common in older cats. Understanding Feline...
Continue Reading
